During the past decade, Neuro-Care Gabriela Klodowska conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neuro-Care Gabriela Klodowska" are "Generalized Tonic Clonic Seizures" (1 trials), "Multiple Sclerosis" (1 trials) and "Relapsing-Remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Neuro-Care Gabriela Klodowska" in a lesser frequency.

Most popular intervention types in "Neuro-Care Gabriela Klodowska" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Pregabalin Dose Level 1" (1 trials), "Pregabalin Dose Level 2" (1 trials) and "dimethyl fumarate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuro-Care Gabriela Klodowska" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neuro-Care Gabriela Klodowska". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neuro-Care Gabriela Klodowska, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neuro-Care Gabriela Klodowska, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".